Amid calls by the World Health Organization to reduce tobacco use and improve lung health on this year’s “World No Tobacco Day,” tobacco industry giant Philip Morris has pushed back, calling on its longtime adversaries in the public health community to group instead around a “World No Smoking Day.” Image Credits: WHO. Continue reading ->
In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading ->
The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading ->
A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading ->
The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading ->
After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading ->
Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading ->
As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading ->
From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading ->
The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading ->